Health Affairs November 13, 2025
Editor’s Note
This article is the latest in the Health Affairs Forefront featured topic, “Health Policy at a Crossroads,” produced with the support of the Commonwealth Fund and the Robert Wood Johnson Foundation. Articles in this topic offer timely analyses of regulatory, legislative, and judicial developments in health policy under the Trump-Vance Administration and the 119th Congress. Health Affairs Forefront alone reviews all submissions then selects, edits, and publishes them only if they meet Forefront’s editorial standards.
On September 26, 2025, a federal district court in Illinois refused to preliminarily block the Illinois prescription drug price-gouging law. The challenger, the Association for Accessible Medicines (AAM), argued the law is unconstitutional under the “dormant Commerce Clause” doctrine. Technically, the court’s decision...
Today's Sponsors
Today's Sponsor